• 1
    Jemal A, Murray T, Samuels A, Ghafoor S, Ward E, Thun MJ. Cancer statistics 2003. CA Cancer J Clin 2003; 53: 526
  • 2
    Zincke H, Utz DC. Surgical management of prostate cancer. In Javadpour N ed. Principles and Management of Urologic Cancer. Baltimore, MD: Williams & Wilkins, 1983: 37291
  • 3
    Vaidya A, Soloway MS, Hawke C, Tiguert R, Civantos F. De novo muscle invasive bladder cancer: Is there a change in trend? J Urol 2001; 165: 4750
  • 4
    Hopkins SC, Ford KS, Soloway MS. Invasive bladder cancer: support for screening. J Urol 1983; 130: 614
  • 5
    Vandermaa SE, Hansen SW, Robert JT et al. Gemcitabine and cisplatin versus methytrexate, vinblastine, doxyrubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multi-national, multi-center Phase III study. J Clin Oncol 2000; 18: 306877
  • 6
    Lokeshwar VB, Soloway MS. Current bladder tumor tests: Does their projected utility fulfil clinical necessity? J Urol 2001; 165: 106777
  • 7
    Soloway MS. Editorial. Do we have a prostatic specific antigen for bladder cancer? J Urol 1999; 161: 4478